List of insiders holdings for PTC THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
HBM Healthcare Investments (Cayman) Ltd. 10% Owner | 2014-11-12 06:05:25 | 1,618,717 0 | 1,618,717 | Form 13D |
CREDIT SUISSE AG Former 10% Owner | 2015-02-06 14:59:25 | 1,183,177 0 | 1,183,177 | Form 13G |
Rothera Mark Chief Commercial Officer | 2017-05-25 16:18:09 | 369,641 9,216 | 378,857 | Form 4 |
Kovacs Shane William Charles Chief Financial Officer | 2017-05-11 17:20:32 | 347,959 0 | 347,959 | Form 4 |
Vulcan Ventures Inc. Vulcan Capital Venture Capital Management I LLC Vulcan Capital Venture Capital I LLC ALLEN PAUL G Cougar Investment Holdings LLC VCVC Management III LLC VCVC III LLC Director | 2016-02-08 21:46:36 | 261,562 0 | 261,562 | Form 13G |
Klein Matthew B. CHIEF EXECUTIVE OFFICER | 2024-04-22 17:20:08 | 225,807 0 | 225,807 | Form 4 |
Peltz Stuart Walter CHIEF EXECUTIVE OFFICER | 2023-02-02 16:22:42 | 166,962 54,903 | 221,865 | Form 4 |
SCHMERTZLER MICHAEL Director | 2024-02-16 16:25:26 | 143,266 0 | 143,266 | Form 4 |
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | 2024-02-16 17:00:39 | 133,702 4,576 | 138,278 | Form 4 |
Boulding Mark Elliott EXEC. VP AND CLO | 2024-02-16 16:10:47 | 137,389 0 | 137,389 | Form 4 |
Hirawat Claudia de Oliveira Ribeiro President | 2015-01-16 19:35:00 | 106,331 194 | 106,525 | Form 4 |
Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | 2024-02-16 17:00:46 | 87,428 0 | 87,428 | Form 4 |
Pauwels Eric CHIEF EXECUTIVE OFFICER | 2024-04-19 17:20:10 | 67,694 0 | 67,694 | Form 4 |
Barth Jay Allan VP, Clinical Development | 2013-06-19 20:57:08 | 62,931 0 | 62,931 | Form 3 |
Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | 2024-05-08 17:20:12 | 59,813 0 | 59,813 | Form 4 |
Gravier Pierre CHIEF FINANCIAL OFFICER | 2024-07-18 17:20:07 | 53,531 0 | 53,531 | Form 4 |
Ong Tuyen Chief Medical Officer | 2017-01-05 19:13:24 | 41,000 0 | 41,000 | Form 4 |
Hill Emily Luisa CHIEF FINANCIAL OFFICER | 2023-03-29 16:19:14 | 38,925 0 | 38,925 | Form 4 |
ALDRICH RICHARD Director | 2015-06-10 18:00:33 | 35,000 0 | 35,000 | Form 4 |
Svoronos Dawn Director | 2022-06-10 16:06:01 | 29,017 0 | 29,017 | Form 4 |
Jacobson Allan Steven Director | 2024-02-16 16:10:43 | 26,348 0 | 26,348 | Form 4 |
STEELE GLENN JR MD PHD Director | 2024-02-16 16:10:19 | 24,500 0 | 24,500 | Form 4 |
Smith Mary L. Director | 2024-02-16 16:10:13 | 23,813 0 | 23,813 | Form 4 |
Souza Marcio Chief Operating Officer | 2020-02-12 16:09:27 | 0 23,560 | 23,560 | Form 4 |
Young Alethia Director | 2024-02-16 16:10:25 | 23,067 0 | 23,067 | Form 4 |
Reeve Emma Director | 2024-02-16 16:10:46 | 21,200 0 | 21,200 | Form 4 |
Bell William F. Jr. Director | 2024-02-16 16:20:42 | 20,333 0 | 20,333 | Form 4 |
Bolte Axel Director | 2013-06-27 21:33:48 | 20,000 0 | 20,000 | Form 4 |
Okey Stephanie Director | 2024-02-16 16:16:57 | 19,867 0 | 19,867 | Form 4 |
SOUTHWELL DAVID P Director | 2024-05-10 17:20:13 | 12,850 1,650 | 14,500 | Form 4 |
ZELDIS JEROME B Director | 2024-05-24 17:20:10 | 14,500 0 | 14,500 | Form 4 |
Renaud Ronald C JR Director | 2017-01-05 19:24:45 | 12,000 0 | 12,000 | Form 4 |
Koppel Adam Director | 2017-01-05 19:24:08 | 12,000 0 | 12,000 | Form 4 |
McDonough Cameron Geoffrey Director | 2017-01-05 19:23:18 | 12,000 0 | 12,000 | Form 4 |
Spiegel Robert J. Chief Medical Officer | 2016-01-06 18:36:44 | 10,000 0 | 10,000 | Form 4 |
Kranda Michael L Director | 2015-03-18 19:26:49 | 2,242 0 | 2,242 | Form 4 |
Complete Pharma Holdings II LLC 10% Owner | 2017-05-02 20:11:22 | 0 0 | 0 | Form 13G |